Valuation: Southern Acids (M)

Market Cap 422M 103M 92.19M 85.16M 77.18M 144M 9.8B 147M 1.02B 406M 5.13B 387M 379M 16.19B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -4.71M -1.15M -1.03M -951K -862K -1.61M -109M -1.64M -11.44M -4.53M -57.33M -4.33M -4.23M -181M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
10-19 Southern Acids (M) Berhad Reports Group Production Results for the Month of September 2026 CI
10-01 Southern Acids (M) Berhad Reassigns Lee Weng Hoong as Principal Officer, Effective October 1, 2026 CI
09-08 Southern Acids (M) Berhad Reports Group Production Results for the Month of August 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
08-26 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-13 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
08-05 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
07-27 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
07-14 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
06-16 Southern Acids (M) Berhad Reports Group Production Results for the Month of May 2026 CI
1 week+0.65%
Current month-0.65%
1 month+0.98%
3 months+0.65%
6 months-2.22%
Current year-3.14%
1 week 3.08
Extreme 3.08
3.11
1 month 3.01
Extreme 3.01
3.18
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.5
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 46 2015-07-14
Chief Tech/Sci/R&D Officer 38 2014-07-15
Corporate Secretary - 2023-03-26
Director TitleAgeSince
Director/Board Member 66 2005-08-09
Director/Board Member 59 2012-03-19
Director/Board Member 58 2023-03-26
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.65%-5.23%-5.23% 103M
+4.88%+3.34%+17.50%+52.94% 47.46B
-0.74%+4.68%-14.56%+31.51% 35.32B
-0.88%+7.46%-12.44%-7.37% 15.93B
+0.07%-3.80%-26.94%-2.27% 10.28B
-0.50%-6.54%-9.09%+9.29% 4.84B
0.00%+3.50%-29.50%-30.93% 4.56B
+3.66%-12.16%-21.74%+302.26% 3.96B
-0.34%+3.21%-2.36%+12.45% 4B
+0.87%+5.71%-5.39%+9.64% 3.66B
Average +0.70%-0.37%-10.97%+37.23% 13.01B
Weighted average by Cap. +1.58%-0.70%-3.48%+35.89%

Financials

2025 2026
Net sales 1.11B 271M 242M 223M 202M 379M 25.7B 385M 2.69B 1.06B 13.46B 1.02B 994M 42.45B 934M 229M 204M 189M 171M 320M 21.69B 325M 2.27B 898M 11.37B 858M 839M 35.83B
Net income 36.7M 8.98M 8.02M 7.41M 6.72M 12.56M 853M 12.77M 89.18M 35.31M 447M 33.71M 33M 1.41B 37.38M 9.15M 8.17M 7.55M 6.84M 12.8M 869M 13.01M 90.82M 35.96M 455M 34.34M 33.6M 1.43B
Net Debt -367M -89.8M -80.19M -74.08M -67.13M -126M -8.52B -128M -891M -353M -4.47B -337M -330M -14.08B -426M -104M -93.22M -86.11M -78.04M -146M -9.91B -148M -1.04B -410M -5.19B -392M -383M -16.37B
Projected Income Statement - Annual - Southern Acids (M)
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
26-10-23 MYR 3.080 0.00% 5,000
26-10-21 MYR 3.080 -0.65% 5,000
26-10-20 MYR 3.100 +1.31% 42,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock